New Delhi: In a transfer to bolster India’s battle towards tuberculosis (TB), HaystackAnalytics has launched ‘TB One,’ a Make-in-India solution designed to boost TB analysis by enabling Subsequent-Technology Sequencing (NGS) at any diagnostic lab or hospital. This all-in-one providing features a pre-sequencing package for Complete Genome Sequencing (WGS), entry to ‘Omega TB’—HaystackAnalytics’ patented scientific reporting software program—and on-demand entry to 2GB of sequencing knowledge.
The Omega TB software program delivers a complete scientific report protecting resistance to 18 anti-TB medication, together with blended infections, non-tuberculous mycobacteria (NTM), and heteroresistance—all inside a single, standardized report. By equipping healthcare suppliers with exact, knowledge-pushed insights, ‘TB One’ goals to enhance TB administration and strengthen India’s battle towards the illness.
The Solution has been unveiled by Dr Anirvan Chatterjee, Co-founder & CEO, of HaystackAnalytics & Dr Rajendra Prasad on the Indian Council of Medical Analysis’s (ICMR) India Innovation Summit: Pioneering Options to Finish TB on March 19, 2025. With this solution genomics-primarily based TB testing would turn out to be extra accessible and scalable by enabling current laboratories to improve to NGS testing for TB with out vital infrastructure modifications. This solution aligns seamlessly with HaystackAnalytics’ mission to make genomics accessible, relevant, and reasonably priced, addressing a important want to remodel molecular diagnostic laboratories into superior genomic services.Emphasizing on the potential of ‘TB One’ solution, Dr. Anirvan Chatterjee, Co-founder and CEO of HaystackAnalytics, mentioned, “We’re empowering current molecular labs to carry out excessive-precision genomic testing with out requiring costly infrastructure modifications. This value-efficient and scalable strategy ensures higher accessibility to superior TB diagnostics throughout India. Every TB One package accommodates reagents to course of 16 samples and requires prior extraction of TB DNA. It seamlessly integrates into current molecular workflows, facilitating environment friendly TB genomic sequencing.”
Dr. Rajendra Prasad, a nationally acclaimed pulmonologist with over 51 years of expertise in TB care and analysis, mentioned, “Drug-resistant TB stays one in all our hardest challenges, and quicker, extra exact diagnostics are the necessity of the hour. ‘TB One’ Solution generally is a sport-changer, bringing superior genomic testing to on a regular basis labs with out main upgrades. By enabling complete drug resistance profiling in a single check, it has the potential to assist in TB care and save numerous lives. It is a essential step towards the journey of TB Mukt Bharat.”
Source link
#HaystackAnalytics #launches #solution #HealthWorld
